BD Diagnostics, Lab21 Developing Aspergillus MDx for BD Max Platform

BD Diagnostics, a segment of Becton Dickinson, and Lab 21 will develop the real-time PCR-based test as an in vitro diagnostic product.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.